Accession Number: | 0001144204-15-059043 |
Date: | 2015-10-12 |
Issuer: | IMMUNE PHARMACEUTICALS INC (IMNP) |
Original Submission Date: |
TEPER DANIEL GEDEON
C/O IMMUNE PHARMACEUTICALS INC.
430 EAST 29TH STREET, SUITE 940
NEW YORK, NY 10016
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2015-10-12 | P | 19,000 | a | $1.30 | 4,520,905 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the transaction reported in this line item was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on september 15, 2015. |